X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SANOFI INDIA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SANOFI INDIA J.B.CHEMICALS/
SANOFI INDIA
 
P/E (TTM) x 14.2 30.3 46.7% View Chart
P/BV x 2.2 5.4 41.8% View Chart
Dividend Yield % 0.2 1.7 10.3%  

Financials

 J.B.CHEMICALS   SANOFI INDIA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
SANOFI INDIA
Dec-16
J.B.CHEMICALS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3184,560 7.0%   
Low Rs2004,400 4.5%   
Sales per share (Unadj.) Rs148.01,028.5 14.4%  
Earnings per share (Unadj.) Rs19.1129.0 14.8%  
Cash flow per share (Unadj.) Rs23.9186.0 12.9%  
Dividends per share (Unadj.) Rs0.5068.00 0.7%  
Dividend yield (eoy) %0.21.5 12.7%  
Book value per share (Unadj.) Rs128.9753.6 17.1%  
Shares outstanding (eoy) m84.8223.03 368.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.4 40.2%   
Avg P/E ratio x13.634.7 39.0%  
P/CF ratio (eoy) x10.824.1 44.9%  
Price / Book Value ratio x2.05.9 33.8%  
Dividend payout %2.652.7 5.0%   
Avg Mkt Cap Rs m21,951103,174 21.3%   
No. of employees `0002.73.6 75.5%   
Total wages/salary Rs m1,8413,592 51.3%   
Avg. sales/employee Rs Th4,590.96,537.7 70.2%   
Avg. wages/employee Rs Th673.4991.4 67.9%   
Avg. net profit/employee Rs Th592.1819.8 72.2%   
INCOME DATA
Net Sales Rs m12,55123,686 53.0%  
Other income Rs m542708 76.5%   
Total revenues Rs m13,09324,394 53.7%   
Gross profit Rs m2,0555,281 38.9%  
Depreciation Rs m4121,313 31.4%   
Interest Rs m9615 638.0%   
Profit before tax Rs m2,0884,661 44.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,691 27.7%   
Profit after tax Rs m1,6192,970 54.5%  
Gross profit margin %16.422.3 73.4%  
Effective tax rate %22.536.3 61.9%   
Net profit margin %12.912.5 102.9%  
BALANCE SHEET DATA
Current assets Rs m7,77815,673 49.6%   
Current liabilities Rs m4,3586,678 65.3%   
Net working cap to sales %27.238.0 71.7%  
Current ratio x1.82.3 76.0%  
Inventory Days Days5576 71.9%  
Debtors Days Days8022 358.6%  
Net fixed assets Rs m5,7138,098 70.5%   
Share capital Rs m170230 73.6%   
"Free" reserves Rs m10,54717,088 61.7%   
Net worth Rs m10,93717,356 63.0%   
Long term debt Rs m00-   
Total assets Rs m15,57425,400 61.3%  
Interest coverage x22.8311.7 7.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.9 86.4%   
Return on assets %11.011.8 93.7%  
Return on equity %14.817.1 86.5%  
Return on capital %20.026.9 74.1%  
Exports to sales %48.724.5 198.9%   
Imports to sales %7.128.0 25.3%   
Exports (fob) Rs m6,1155,801 105.4%   
Imports (cif) Rs m8896,627 13.4%   
Fx inflow Rs m6,1697,145 86.3%   
Fx outflow Rs m1,2856,846 18.8%   
Net fx Rs m4,884299 1,633.4%   
CASH FLOW
From Operations Rs m1,3973,226 43.3%  
From Investments Rs m-320-1,555 20.6%  
From Financial Activity Rs m-1,196-1,818 65.8%  
Net Cashflow Rs m-102-147 69.6%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 60.4 0.5%  
Indian inst/Mut Fund % 3.4 14.4 23.5%  
FIIs % 3.9 14.6 26.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 15,184 200.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 18, 2017 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - NATCO PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS